Tissue | Expression Dynamics | Abbreviation |
Colorectum (GSE201348) | | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Esophagus | | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
GC | | CAG: Chronic atrophic gastritis |
CAG with IM: Chronic atrophic gastritis with intestinal metaplasia |
CSG: Chronic superficial gastritis |
GC: Gastric cancer |
SIM: Severe intestinal metaplasia |
WIM: Wild intestinal metaplasia |
Liver | | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Oral Cavity | | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Skin | | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0048732 | Colorectum | AD | gland development | 149/3918 | 436/18723 | 6.07e-11 | 6.33e-09 | 149 |
GO:0032868 | Colorectum | AD | response to insulin | 91/3918 | 264/18723 | 2.02e-07 | 8.48e-06 | 91 |
GO:1901653 | Colorectum | AD | cellular response to peptide | 114/3918 | 359/18723 | 8.32e-07 | 2.88e-05 | 114 |
GO:0032869 | Colorectum | AD | cellular response to insulin stimulus | 72/3918 | 203/18723 | 1.10e-06 | 3.68e-05 | 72 |
GO:0030879 | Colorectum | AD | mammary gland development | 53/3918 | 137/18723 | 1.46e-06 | 4.58e-05 | 53 |
GO:0071375 | Colorectum | AD | cellular response to peptide hormone stimulus | 95/3918 | 290/18723 | 1.50e-06 | 4.66e-05 | 95 |
GO:0043434 | Colorectum | AD | response to peptide hormone | 126/3918 | 414/18723 | 2.70e-06 | 7.86e-05 | 126 |
GO:0006984 | Colorectum | AD | ER-nucleus signaling pathway | 21/3918 | 46/18723 | 1.47e-04 | 2.08e-03 | 21 |
GO:0050878 | Colorectum | AD | regulation of body fluid levels | 108/3918 | 379/18723 | 2.54e-04 | 3.20e-03 | 108 |
GO:0045785 | Colorectum | AD | positive regulation of cell adhesion | 122/3918 | 437/18723 | 2.65e-04 | 3.28e-03 | 122 |
GO:0007589 | Colorectum | AD | body fluid secretion | 33/3918 | 93/18723 | 8.26e-04 | 8.13e-03 | 33 |
GO:0032933 | Colorectum | AD | SREBP signaling pathway | 9/3918 | 15/18723 | 1.11e-03 | 1.01e-02 | 9 |
GO:0071501 | Colorectum | AD | cellular response to sterol depletion | 9/3918 | 16/18723 | 2.06e-03 | 1.64e-02 | 9 |
GO:1903706 | Colorectum | AD | regulation of hemopoiesis | 99/3918 | 367/18723 | 3.08e-03 | 2.28e-02 | 99 |
GO:0120162 | Colorectum | AD | positive regulation of cold-induced thermogenesis | 32/3918 | 97/18723 | 3.74e-03 | 2.63e-02 | 32 |
GO:0007595 | Colorectum | AD | lactation | 18/3918 | 47/18723 | 4.81e-03 | 3.25e-02 | 18 |
GO:0006991 | Colorectum | AD | response to sterol depletion | 9/3918 | 18/18723 | 5.82e-03 | 3.67e-02 | 9 |
GO:0031056 | Colorectum | AD | regulation of histone modification | 45/3918 | 152/18723 | 7.05e-03 | 4.31e-02 | 45 |
GO:0106106 | Colorectum | AD | cold-induced thermogenesis | 43/3918 | 144/18723 | 7.05e-03 | 4.31e-02 | 43 |
GO:0120161 | Colorectum | AD | regulation of cold-induced thermogenesis | 43/3918 | 144/18723 | 7.05e-03 | 4.31e-02 | 43 |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ZBTB7B | MLUM | Breast | IDC | ENC1,FASN,SIM2, etc. | 5.52e-01 | |
ZBTB7B | TREG | Cervix | CC | CORO1B,ZNF700,CD40LG, etc. | 1.29e-01 | |
ZBTB7B | CD4TN | Cervix | Healthy | CORO1B,ZNF700,CD40LG, etc. | 1.55e-01 | |
ZBTB7B | CD8TEXP | Cervix | Healthy | CORO1B,ZNF700,CD40LG, etc. | 1.10e-01 | |
ZBTB7B | TREG | Cervix | Healthy | CORO1B,ZNF700,CD40LG, etc. | 1.03e-01 | |
ZBTB7B | TFH | Cervix | Healthy | CORO1B,ZNF700,CD40LG, etc. | 1.24e-01 | |
ZBTB7B | TREG | Cervix | HSIL_HPV | CORO1B,ZNF700,CD40LG, etc. | 1.07e-01 | |
ZBTB7B | TFH | Cervix | HSIL_HPV | CORO1B,ZNF700,CD40LG, etc. | 1.36e-01 | |
ZBTB7B | CD4TN | Cervix | N_HPV | CORO1B,ZNF700,CD40LG, etc. | 2.56e-01 | |
ZBTB7B | TREG | Cervix | N_HPV | CORO1B,ZNF700,CD40LG, etc. | 8.11e-02 | |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZBTB7B | SNV | Missense_Mutation | | c.768N>T | p.Glu256Asp | p.E256D | O15156 | protein_coding | tolerated(0.6) | benign(0.011) | TCGA-66-2756-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
ZBTB7B | SNV | Missense_Mutation | | c.928N>C | p.Glu310Gln | p.E310Q | O15156 | protein_coding | tolerated(0.41) | possibly_damaging(0.636) | TCGA-66-2782-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unspecific | | PD |
ZBTB7B | SNV | Missense_Mutation | novel | c.1241N>T | p.Gly414Val | p.G414V | O15156 | protein_coding | deleterious(0.05) | possibly_damaging(0.811) | TCGA-68-7757-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ZBTB7B | SNV | Missense_Mutation | novel | c.448G>T | p.Ala150Ser | p.A150S | O15156 | protein_coding | tolerated(1) | benign(0.033) | TCGA-NC-A5HF-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
ZBTB7B | SNV | Missense_Mutation | novel | c.1215N>C | p.Glu405Asp | p.E405D | O15156 | protein_coding | deleterious(0) | probably_damaging(0.983) | TCGA-BA-5152-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ZBTB7B | SNV | Missense_Mutation | novel | c.937G>A | p.Glu313Lys | p.E313K | O15156 | protein_coding | tolerated(0.28) | benign(0.351) | TCGA-CR-7385-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | unknown | SD |
ZBTB7B | SNV | Missense_Mutation | | c.301G>T | p.Gly101Cys | p.G101C | O15156 | protein_coding | deleterious_low_confidence(0.04) | probably_damaging(0.977) | TCGA-CV-7090-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ZBTB7B | SNV | Missense_Mutation | novel | c.205G>A | p.Asp69Asn | p.D69N | O15156 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-UF-A7JV-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
ZBTB7B | SNV | Missense_Mutation | novel | c.1430A>G | p.Asp477Gly | p.D477G | O15156 | protein_coding | deleterious(0) | benign(0.143) | TCGA-HC-A8D1-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 7 | Unknown | Unknown | SD |
ZBTB7B | SNV | Missense_Mutation | rs140676784 | c.239G>A | p.Arg80His | p.R80H | O15156 | protein_coding | tolerated(0.14) | possibly_damaging(0.818) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD |